Drs. Ringold and Weiss contributed equally to this work.
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
Version of Record online: 24 SEP 2013
Copyright © 2013 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 65, Issue 10, pages 2499–2512, October 2013
How to Cite
Ringold, S., Weiss, P. F., Beukelman, T., DeWitt, E. M., Ilowite, N. T., Kimura, Y., Laxer, R. M., Lovell, D. J., Nigrovic, P. A., Robinson, A. B. and Vehe, R. K. (2013), 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications. Arthritis & Rheumatism, 65: 2499–2512. doi: 10.1002/art.38092
This article is published simultaneously in the October 2013 issue of Arthritis Care & Research.
The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.
Members of the Core Expert Panel: Timothy Beukelman, Esi Morgan DeWitt, Norman T. Ilowite, Yukiko Kimura, Ronald M. Laxer, Daniel J. Lovell, Peter A. Nigrovic, Sarah Ringold, Angela Byun Robinson, Richard K. Vehe, and Pamela F. Weiss.
Members of the Task Force Panel: Mara Becker, Robert A. Colbert, Vincent Delgaizo, Pavla Dolezalova, Polly Ferguson, Chris Feudtner, Sheila Angeles-Han, Alberto Martini, Murray Passo, Sampath Prahalad, Marilynn Punaro, Rayfel Schneider, David D. Sherry, and Carol A. Wallace.
- Issue online: 24 SEP 2013
- Version of Record online: 24 SEP 2013
- Manuscript Accepted: 2 JUL 2013
- Manuscript Received: 5 MAR 2013
- Agency for Healthcare Research and Quality for the duration of this project. Grant Number: K12HS019482
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH. Grant Number: 1-K23-AR059749-01A1
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.